Tirzepatide, initially approved by the FDA in 2022 as a treatment for type 2 diabetes, has also garnered attention for its potential in aiding weight loss. As an injectable medication, tirzepatide is a combination of two classes of drugs: glucagon-like peptide-1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists. Due to its unique … Read more
Semaglutide and tirzepatide are two medications that have gained popularity in recent years for weight loss and management of type 2 diabetes. Both drugs work by regulating blood sugar levels and suppressing appetite. However, some people may wonder if it is safe to mix the two medications together for even greater weight loss results. Limited … Read more
Compounded tirzepatide is a medication used to manage weight in patients with obesity. It is a relatively new drug that has been approved by the FDA for use in adults. However, there is some confusion regarding the storage requirements of compounded tirzepatide. Specifically, many people wonder whether or not the medication needs to be refrigerated. … Read more
Compounded Tirzepatide is a medication that is used to treat type 2 diabetes, as well as obesity. The drug is a type of GLP-1 receptor agonist, which means that it works by mimicking the effects of a hormone called glucagon-like peptide-1 (GLP-1) in the body. GLP-1 helps to regulate blood sugar levels by stimulating insulin … Read more
Tirzepatide is a recently approved medication that is making headlines as a novel and effective treatment for weight loss. The U.S. Food and Drug Administration (FDA) approved this injectable drug, marketed under the name Zepbound, for chronic weight management in adults with obesity, which is defined as a body mass index (BMI) of 30 kilograms … Read more
